Summary of Key Points
On July 10th, the National Health Commission publicly disclosed the fourth batch of 28 cases of research misconduct, involving medical staff from hospitals in Shanxi, Jiangxi, Guangdong, Guangxi, Chongqing, Xinjiang, and other regions. The types of misconduct included buying and selling experimental data, ghostwriting or submitting papers on behalf of others, co-authoring without actual contribution, and fabricating or manipulating research records. The penalties ranged from admonitory talks to a lifetime ban from participating in national research projects, with a focus on punishing the corresponding authors and first authors (project leaders/main executors). Some other authors who made no substantive contributions received only warning education. This approach reflects a regulatory stance that emphasizes severe punishment for primary responsible parties while distinguishing different levels of responsibility, sending a strong signal that research integrity is not tolerated at all.
Common Misconduct in Research
The misconduct cited in this report are all well-known shortcuts within the scientific community. To put it simply:
- Buying and Selling Experimental Data: Researchers who don’t want to conduct experiments themselves (as they are time-consuming and costly) buy fake data instead. For example, Jia Junqing’s team from Bethune Hospital in Shanxi relied on purchased data for two of their papers.
- Ghostwriting or Submitting Papers on Behalf of Others: They save the effort of writing the papers by entrusting them to third-party agencies, which handle everything from content creation and formatting to submission to journals. This is what Wu Zhiying’s team from Nanchang 334 Hospital did.
- Co-authoring without Contribution: Individuals who didn’t participate in the research still appear as authors on the papers (for example, leaders or colleagues who reap the benefits of others’ work). Zhang Ping’s team from Jiangxi People’s Hospital is cited for this practice in multiple papers.
- Fabricating or Manipulating Records: If experiments were not conducted or the results were unsatisfactory, researchers would fabricate the process or alter data (for instance, turning failed experiments into successful ones), as demonstrated by Peng Ying’s team from Jiangxi People’s Hospital.
Serious Penalties
The penalties this time are not mere formality; they directly affect researchers’ careers:
- Most Severe Penalty: A lifetime ban from participating in national research projects. This means they will no longer be eligible for government-funded research funding and effectively retire from the field.
- Regular Heavy Penalties: A 10-year ban on participating in projects, applying for professional titles, or serving as reviewers. Most of the primary responsible individuals received such penalties, including Jia Junqing from Shanxi and Chen Xuelian from Guangdong.
- Financial Repayment: Researchers must return any grants or funding they received for their papers, resulting in financial losses.
- Credit Damage: Their names are recorded in a database of serious research integrity violations, putting them on a “blacklist” that affects future job opportunities and collaborations.
Clear Division of Responsibility
The responsibility for the misconduct is clearly defined:
- Corresponding Authors (Project Leaders): They receive the harshest penalties because they are responsible for the authenticity of the papers. Zhang Ping, as a corresponding author in several fraudulent cases, was banned from participating in projects for life.
- First Authors (Main Executors): Their penalties are less severe but still significant, as they are directly involved in writing the papers or conducting experiments. For example, Shang Peng was banned from projects for 3 to 10 years.
- Other Authors: If they truly did not participate in the research (such as those who were used as co-authors), they may be exempted from punishment or receive only warning education to avoid unfair accusations.
The Motivation for Risky Behavior
The root cause of this behavior is a paper-centric evaluation system:
- Career Advancement: Hospitals and universities use the number of papers and their journal impact factor as key criteria for promotions. For doctors seeking higher ranks, a certain number of SCI papers is required.
- Project Funding and Awards: National research projects and internal hospital awards are linked to the number of published papers.
- Cost Savings: Conducting genuine experiments can take years and may not be successful, while buying data or ghostwriting papers provides a quicker and more reliable way to meet publication requirements.
The Message from the Announcement
This announcement is a clear signal that research integrity is a non-negotiable principle:
- It serves as a warning to researchers that fraud is a serious issue that can ruin their careers.
- It aims to purify the research environment by ensuring that only genuine research is recognized and supported.
- It pushes hospitals and universities to reform their evaluation systems, reducing reliance on the quantity of papers and focusing more on the practical value of research outcomes.
In summary, this announcement serves as a stark reminder to the scientific community: There is no room for fraud. Integrity is the foundation of research, and it cannot be compromised.